Norma C Gutierrez

Norma C Gutierrez

Universidad de Salamanca

H-index: 70

Europe-Spain

About Norma C Gutierrez

Norma C Gutierrez, With an exceptional h-index of 70 and a recent h-index of 41 (since 2020), a distinguished researcher at Universidad de Salamanca, specializes in the field of mieloma, linfoma, citogenética, genómica.

His recent articles reflect a diverse array of research interests and contributions to the field:

A Differential Privacy protection-based federated deep learning framework to fog-embedded architectures

Quantification of cyclin D1 and D2 proteins in multiple myeloma identifies different expression patterns from those revealed by gene expression profiling

Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously …

Predictors of unsustained measurable residual disease negativity in transplant-eligible patients with multiple myeloma

The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression

Biological and Clinical Significance of Undetectable Circulating Tumor Cells (CTCs) in Patients (Pts) with Multiple Myeloma (MM)

Deep-learning based detection for cyber-attacks in iot networks: A distributed attack detection framework

P832: PROSPECTIVE REAL-WORLD EVALUATION OF THE PREVALENCE OF T (11; 14) IN MULTIPLE MYELOMA: THIRD INTERIM ANALYSIS FROM THE MEDICI STUDY

Norma C Gutierrez Information

University

Position

___

Citations(all)

17130

Citations(since 2020)

6392

Cited By

13192

hIndex(all)

70

hIndex(since 2020)

41

i10Index(all)

191

i10Index(since 2020)

141

Email

University Profile Page

Universidad de Salamanca

Google Scholar

View Google Scholar Profile

Norma C Gutierrez Skills & Research Interests

mieloma

linfoma

citogenética

genómica

Top articles of Norma C Gutierrez

Title

Journal

Author(s)

Publication Date

A Differential Privacy protection-based federated deep learning framework to fog-embedded architectures

Engineering Applications of Artificial Intelligence

Norma Gutiérrez

Beatriz Otero

Eva Rodríguez

Gladys Utrera

Sergi Mus

...

2024/4/1

Quantification of cyclin D1 and D2 proteins in multiple myeloma identifies different expression patterns from those revealed by gene expression profiling

Haematologica

Ignacio J Cardona-Benavides

Irena Misiewicz-Krzeminska

Elizabeta A Rojas

Cristina De Ramón

Antonio Sanz-Solas

...

2024/3/3

Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously …

Journal of Clinical Oncology

Vincent Camus

Catherine Thieblemont

Philippe Gaulard

Morgane Cheminant

Rene-Olivier Casasnovas

...

2024/2/16

Predictors of unsustained measurable residual disease negativity in transplant-eligible patients with multiple myeloma

Blood

Camila Guerrero

Noemi Puig

María-Teresa Cedena

María-José Calasanz

Norma C Gutierrez

...

2024/2/15

The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression

Blood Cancer Journal

A Medina-Herrera

I Vazquez

I Cuenca

JM Rosa-Rosa

B Ariceta

...

2024/4/29

Biological and Clinical Significance of Undetectable Circulating Tumor Cells (CTCs) in Patients (Pts) with Multiple Myeloma (MM)

Blood

Juan-José Garcés

Rosalinda Termini

Esperanza Martín-Sánchez

Marta Lasa

Jose J Perez

...

2023/11/28

Deep-learning based detection for cyber-attacks in iot networks: A distributed attack detection framework

Journal of Network and Systems Management

Olivia Jullian

Beatriz Otero

Eva Rodriguez

Norma Gutierrez

Héctor Antona

...

2023/4

P832: PROSPECTIVE REAL-WORLD EVALUATION OF THE PREVALENCE OF T (11; 14) IN MULTIPLE MYELOMA: THIRD INTERIM ANALYSIS FROM THE MEDICI STUDY

HemaSphere

Maria Gavriatopoulou

Andrew Spencer

Daniel Coriu

Fernando Escalante Barrigón

Roman Hájek

...

2023/8/1

Isolated and Dynamic Peripheral Blood Residual Disease Status Characterized By Mass Spectrometry Predicts Outcome in Patients with High Risk Smoldering Multiple Myeloma Treated …

Blood

Noemi Puig

Cristina Agullo

Teresa Contreras

Bruno Paiva

Maria Teresa Cedena Romero

...

2023/11/28

Multiple myeloma with t (11; 14): impact of novel agents on outcome

Blood Cancer Journal

Borja Puertas

Verónica González-Calle

Eduardo Sobejano-Fuertes

Fernando Escalante

Beatriz Rey-Bua

...

2023/3/20

P848: EXPRESSION PROFILE OF BCL-2 FAMILY PROTEINS IN MULTIPLE MYELOMA.

HemaSphere

Cristina De Ramón Sánchez

Elizabeta A Rojas

Irena Misiewicz-Krzeminska

Ignacio J Cardona-Benavides

Myriam Cuadrado

...

2023/8/1

Early Identification of Very High Risk Patients with Diffuse Large B Cell Lymphoma (DLBCL) By PET-CT

Blood

Almudena Cabero Martínez

Luis Gonzaga Diaz Gonzalez

Carlos Montes

María Cortés-Rodríguez

Norma C Gutierrez

...

2023/11/2

Novel agents as main drivers for continued improvement in survival in multiple myeloma

Cancers

Borja Puertas

Verónica González-Calle

Eduardo Sobejano-Fuertes

Fernando Escalante

José A Queizán

...

2023/3/2

Molecular characterization of diffuse large‐B cell lymphoma by liquid biopsy at diagnosis and during follow‐up. OBO" Euroclonality‐NGS group" &" Grupo Colaborativo Linfomas y …

Hematological Oncology

M Alcoceba

JP Stewart

MG Álvarez

C Jiménez

A Medina

...

2023/6

P-367 High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience

Clinical Lymphoma Myeloma and Leukemia

Paula Rodriguez-Otero

Veronica Gonzalez-Calle

Maria-Jose Calasanz

Teresa Cedena

Noemi Puig

...

2023/9/1

Early progression in follicular lymphoma in the absence of histological transformation or high‐risk Follicular Lymphoma International Prognostic Index still has a favourable …

British Journal of Haematology

Ana Muntañola

Pablo Mozas

Santiago Mercadal

Maria Huguet

Sabela Bobillo

...

2023/2

Induction (MATRix) Followed by Transplantation in Primary Central Nervous System Lymphoma. Experience of the GELTAMO (Grupo Español de Linfoma y Trasplante de Medula Ósea)

Hematological Oncology

P Lopez‐Pereira

S Romero‐Dominguez

F Martin‐Moro

AC Caballero‐Gonzalez

A Lopez‐Garcia

...

2023/6

OA-20 Genomic profiling of high-risk smoldering myeloma patients treated with a curative strategy: a biological study of the phase II GEM CESAR clinical trial

Clinical Lymphoma Myeloma and Leukemia

Alejandro Medina

Iria Vázquez

Isabel Cuenca

Juan Manuel Rosa

Cristina Jiménez

...

2023/9/1

Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma: New Approved Options

Alejandro Martín García-Sancho

Almudena Cabero

Norma C Gutiérrez

2023/12/22

ROMIDEPSIN PLUS CHOP VERSUS CHOP IN PATIENTS WITH PREVIOUSLY UNTREATED PERIPHERAL T‐CELL LYMPHOMA: FINAL ANALYSIS OF THE RO‐CHOP TRIAL

Hematological Oncology

V Camus

C Thieblemont

P Gaulard

M Cheminant

R Casasnovas

...

2023/6

See List of Professors in Norma C Gutierrez University(Universidad de Salamanca)